|
Market Closed -
Nasdaq
20:00:00 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 73.39 USD | +2.16% |
|
+1.44% | +12.39% |
| 10-05 | Monopar Therapeutics Insider Sold Shares Worth $659,387, According to a Recent SEC Filing | MT |
| 09-21 | Monopar Therapeutics Inc.(NasdaqCM:MNPR) added to S&P Biotechnology Select Industry Index | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MNPR | Delayed | |
CBOE
| MNPR | Real-time | |
|
Deutsche Boerse AG
| 1IY0 | Delayed | |
|
Boerse Muenchen
| 1IY0 | Real-time | |
|
Tradegate
| 1IY0 | Real-time | |
|
Börse Stuttgart
| 1IY0 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 83.98 | 123.84 | 119.21 |
| Spread/Res. | -12.61% | -40.74% | -38.44% |
| Spread/Supp. | +5.95% | +32.95% | +37.95% |
| Support | 69.27 | 55.2 | 53.2 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MNPR Stock
- Charts Monopar Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
